Population pharmacokinetic and pharmacodynamic modelling of the antimalarial chemotherapy chlorproguanil/dapsone.
Research output: Contribution to journal › Article › peer-review
Standard Standard
Population pharmacokinetic and pharmacodynamic modelling of the antimalarial chemotherapy chlorproguanil/dapsone. / Simpson, J.A.; Hughes, D.; Manyando, C. et al.
In: British Journal of Clinical Pharmacology, Vol. 61, No. 3, 01.03.2006, p. 289-300.
In: British Journal of Clinical Pharmacology, Vol. 61, No. 3, 01.03.2006, p. 289-300.
Research output: Contribution to journal › Article › peer-review
HarvardHarvard
Simpson, JA, Hughes, D, Manyando, C, Bojang, K, Aarons, L, Winstanley, P, Edwards, G, Watkins, WA & Ward, S 2006, 'Population pharmacokinetic and pharmacodynamic modelling of the antimalarial chemotherapy chlorproguanil/dapsone.', British Journal of Clinical Pharmacology, vol. 61, no. 3, pp. 289-300. https://doi.org/10.1111/j.1365-2125.2005.02567.x
APA
Simpson, J. A., Hughes, D., Manyando, C., Bojang, K., Aarons, L., Winstanley, P., Edwards, G., Watkins, W. A., & Ward, S. (2006). Population pharmacokinetic and pharmacodynamic modelling of the antimalarial chemotherapy chlorproguanil/dapsone. British Journal of Clinical Pharmacology, 61(3), 289-300. https://doi.org/10.1111/j.1365-2125.2005.02567.x
CBE
Simpson JA, Hughes D, Manyando C, Bojang K, Aarons L, Winstanley P, Edwards G, Watkins WA, Ward S. 2006. Population pharmacokinetic and pharmacodynamic modelling of the antimalarial chemotherapy chlorproguanil/dapsone. British Journal of Clinical Pharmacology. 61(3):289-300. https://doi.org/10.1111/j.1365-2125.2005.02567.x
MLA
Simpson, J.A. et al. "Population pharmacokinetic and pharmacodynamic modelling of the antimalarial chemotherapy chlorproguanil/dapsone.". British Journal of Clinical Pharmacology. 2006, 61(3). 289-300. https://doi.org/10.1111/j.1365-2125.2005.02567.x
VancouverVancouver
Simpson JA, Hughes D, Manyando C, Bojang K, Aarons L, Winstanley P et al. Population pharmacokinetic and pharmacodynamic modelling of the antimalarial chemotherapy chlorproguanil/dapsone. British Journal of Clinical Pharmacology. 2006 Mar 1;61(3):289-300. doi: 10.1111/j.1365-2125.2005.02567.x
Author
RIS
TY - JOUR
T1 - Population pharmacokinetic and pharmacodynamic modelling of the antimalarial chemotherapy chlorproguanil/dapsone.
AU - Simpson, J.A.
AU - Hughes, D.
AU - Manyando, C.
AU - Bojang, K.
AU - Aarons, L.
AU - Winstanley, P.
AU - Edwards, G.
AU - Watkins, W.A.
AU - Ward, S.
PY - 2006/3/1
Y1 - 2006/3/1
KW - PHARMACOLOGY & PHARMACY
U2 - 10.1111/j.1365-2125.2005.02567.x
DO - 10.1111/j.1365-2125.2005.02567.x
M3 - Article
VL - 61
SP - 289
EP - 300
JO - British Journal of Clinical Pharmacology
JF - British Journal of Clinical Pharmacology
SN - 0306-5251
IS - 3
ER -